Loading...
OTCM
YTENQ
Market cap0kUSD
Jul 06, Last price  
0.00USD
1D
0.00%
1Q
0.00%
Jan 2017
-100.00%
IPO
-100.00%
Name

Yield10 Bioscience Inc

Chart & Performance

D1W1MN
OTCM:YTENQ chart
P/E
—
P/S
0.00
EPS
—
Div Yield, %
—
Shrs. gr., 5y
100.00%
Rev. gr., 5y
-35.94%
Revenues
60k
-86.67%
3,678,2042,781,0004,590,0001,683,0001,555,0001,425,000448,0001,425,00042,316,0005,394,0002,800,0002,594,0001,159,000944,000556,000806,000799,000614,000450,00060,000
Net income
-14m
L+6.55%
-5,054,511-7,625,427-16,062,000-27,875,000-36,005,000-37,957,000-38,803,000-38,785,0003,630,000-30,506,000-29,534,000-23,681,000-7,604,000-9,396,000-9,185,000-12,956,000-10,206,000-11,031,000-13,566,000-14,455,000
CFO
-10m
L-11.72%
-980,667-4,394,184-3,603,000-10,900,000-18,392,000-25,759,000-31,995,000-31,731,000-31,736,000-26,648,000-24,244,000-21,863,000-14,700,000-8,202,000-8,754,000-8,654,000-8,659,000-9,253,000-11,404,000-10,068,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Yield10 Bioscience, Inc. is an agricultural biotechnology firm dedicated to creating advanced solutions that can significantly boost crop productivity across the United States and Canada. Utilizing its proprietary Trait Factory – an innovative gene discovery platform – the company develops enhanced varieties of oilseed Camelina sativa for exclusive seed products. Additionally, it identifies valuable genetic characteristics applicable to both the agricultural and food sectors. Yield10 Bioscience maintains licensing agreements with several key industry players, including GDM Seeds, J. R. Simplot, Forage Genetics International, LLC, and Bayer AG. The company, incorporated in 1992, rebranded from Metabolix, Inc. to Yield10 Bioscience, Inc. in January 2017. Its corporate headquarters are located in Woburn, Massachusetts.
URL
https://www.yield10bio.com/
IPO date
Nov 10, 2006
Employees
30
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT